Summary

The global market for Stem Cell Banking was estimated to be worth US$ 2054 million in 2024 and is forecast to a readjusted size of US$ 3319 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Stem Cell Banking refers to the human stem cell transplantation for the purpose, with acquisition, processing, preservation and provides the ability to differentiate stem cell storage bank, has been called the "life bank". Storage per Year means the new storage of one year.
Market Driver: The stem cell banking market is driven by the increasing prevalence of chronic diseases, rising awareness of regenerative medicine, and advancements in stem cell research. With conditions such as leukemia, neurodegenerative disorders, and cardiovascular diseases on the rise, the demand for stem cell therapies has grown significantly. Moreover, government initiatives and private sector investments in biotechnology have further accelerated the expansion of the market. The development of automated cryopreservation techniques and improved storage facilities has also enhanced the efficiency and reliability of stem cell banking, encouraging more individuals and healthcare institutions to adopt these services.
Market Challenge: Despite its growth potential, the stem cell banking market faces several challenges, including high costs and stringent regulatory frameworks. The collection, processing, and long-term storage of stem cells require substantial financial investment, which can be a barrier for many consumers. Additionally, ethical concerns and regulatory complexities vary across regions, making it difficult for companies to expand globally. Ensuring the viability and quality of stored stem cells over extended periods also presents technical challenges, requiring continuous research and innovation to maintain industry standards and build consumer trust.
Global Stem Cell Banking key players include CCBC, CBR, ViaCord, Vcanbio, cells4life, etc. Global top five manufacturers hold a share about 35%. Asia-Pacific is the largest market, with a share about 40%, followed by North America, with a share about 30 percent. In terms of product, Umbilical Cord Blood Stem Cell is the largest segment, with a share about 60%. And in terms of application, the largest application is Diseases Therapy, followed by Healthcare.
This report aims to provide a comprehensive presentation of the global market for Stem Cell Banking, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Stem Cell Banking by region & country, by Type, and by Application.
The Stem Cell Banking market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Banking.
Market Segmentation
By Company
CCBC
CBR
ViaCord
Esperite
Vcanbio
Boyalife
LifeCell
Crioestaminal
RMS Regrow
Cordlife
PBKM FamiCord
cells4life
Beikebiotech
StemCyte
Cryo-cell
Cellsafe Biotech
PacifiCord
Americord
Krio
Familycord
Cryo Stemcell
Stemade Biotech
Segment by Type
Umbilical Cord Blood Stem Cell
Embryonic Stem Cell
Adult Stem Cell
Other
Segment by Application
Diseases Therapy
Healthcare
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Stem Cell Banking company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Stem Cell Banking in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Stem Cell Banking in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Stem Cell Banking Product Introduction
1.2 Global Stem Cell Banking Market Size Forecast (2020-2031)
1.3 Stem Cell Banking Market Trends & Drivers
1.3.1 Stem Cell Banking Industry Trends
1.3.2 Stem Cell Banking Market Drivers & Opportunity
1.3.3 Stem Cell Banking Market Challenges
1.3.4 Stem Cell Banking Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Stem Cell Banking Players Revenue Ranking (2024)
2.2 Global Stem Cell Banking Revenue by Company (2020-2025)
2.3 Key Companies Stem Cell Banking Manufacturing Base Distribution and Headquarters
2.4 Key Companies Stem Cell Banking Product Offered
2.5 Key Companies Time to Begin Mass Production of Stem Cell Banking
2.6 Stem Cell Banking Market Competitive Analysis
2.6.1 Stem Cell Banking Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Stem Cell Banking Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Banking as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Umbilical Cord Blood Stem Cell
3.1.2 Embryonic Stem Cell
3.1.3 Adult Stem Cell
3.1.4 Other
3.2 Global Stem Cell Banking Sales Value by Type
3.2.1 Global Stem Cell Banking Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Stem Cell Banking Sales Value, by Type (2020-2031)
3.2.3 Global Stem Cell Banking Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diseases Therapy
4.1.2 Healthcare
4.2 Global Stem Cell Banking Sales Value by Application
4.2.1 Global Stem Cell Banking Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Stem Cell Banking Sales Value, by Application (2020-2031)
4.2.3 Global Stem Cell Banking Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Stem Cell Banking Sales Value by Region
5.1.1 Global Stem Cell Banking Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Stem Cell Banking Sales Value by Region (2020-2025)
5.1.3 Global Stem Cell Banking Sales Value by Region (2026-2031)
5.1.4 Global Stem Cell Banking Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Stem Cell Banking Sales Value, 2020-2031
5.2.2 North America Stem Cell Banking Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Stem Cell Banking Sales Value, 2020-2031
5.3.2 Europe Stem Cell Banking Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Stem Cell Banking Sales Value, 2020-2031
5.4.2 Asia Pacific Stem Cell Banking Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Stem Cell Banking Sales Value, 2020-2031
5.5.2 South America Stem Cell Banking Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Stem Cell Banking Sales Value, 2020-2031
5.6.2 Middle East & Africa Stem Cell Banking Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Stem Cell Banking Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Stem Cell Banking Sales Value, 2020-2031
6.3 United States
6.3.1 United States Stem Cell Banking Sales Value, 2020-2031
6.3.2 United States Stem Cell Banking Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Stem Cell Banking Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Stem Cell Banking Sales Value, 2020-2031
6.4.2 Europe Stem Cell Banking Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Stem Cell Banking Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Stem Cell Banking Sales Value, 2020-2031
6.5.2 China Stem Cell Banking Sales Value by Type (%), 2024 VS 2031
6.5.3 China Stem Cell Banking Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Stem Cell Banking Sales Value, 2020-2031
6.6.2 Japan Stem Cell Banking Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Stem Cell Banking Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Stem Cell Banking Sales Value, 2020-2031
6.7.2 South Korea Stem Cell Banking Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Stem Cell Banking Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Stem Cell Banking Sales Value, 2020-2031
6.8.2 Southeast Asia Stem Cell Banking Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Stem Cell Banking Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Stem Cell Banking Sales Value, 2020-2031
6.9.2 India Stem Cell Banking Sales Value by Type (%), 2024 VS 2031
6.9.3 India Stem Cell Banking Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 CCBC
7.1.1 CCBC Profile
7.1.2 CCBC Main Business
7.1.3 CCBC Stem Cell Banking Products, Services and Solutions
7.1.4 CCBC Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.1.5 CCBC Recent Developments
7.2 CBR
7.2.1 CBR Profile
7.2.2 CBR Main Business
7.2.3 CBR Stem Cell Banking Products, Services and Solutions
7.2.4 CBR Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.2.5 CBR Recent Developments
7.3 ViaCord
7.3.1 ViaCord Profile
7.3.2 ViaCord Main Business
7.3.3 ViaCord Stem Cell Banking Products, Services and Solutions
7.3.4 ViaCord Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.3.5 ViaCord Recent Developments
7.4 Esperite
7.4.1 Esperite Profile
7.4.2 Esperite Main Business
7.4.3 Esperite Stem Cell Banking Products, Services and Solutions
7.4.4 Esperite Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.4.5 Esperite Recent Developments
7.5 Vcanbio
7.5.1 Vcanbio Profile
7.5.2 Vcanbio Main Business
7.5.3 Vcanbio Stem Cell Banking Products, Services and Solutions
7.5.4 Vcanbio Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.5.5 Vcanbio Recent Developments
7.6 Boyalife
7.6.1 Boyalife Profile
7.6.2 Boyalife Main Business
7.6.3 Boyalife Stem Cell Banking Products, Services and Solutions
7.6.4 Boyalife Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.6.5 Boyalife Recent Developments
7.7 LifeCell
7.7.1 LifeCell Profile
7.7.2 LifeCell Main Business
7.7.3 LifeCell Stem Cell Banking Products, Services and Solutions
7.7.4 LifeCell Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.7.5 LifeCell Recent Developments
7.8 Crioestaminal
7.8.1 Crioestaminal Profile
7.8.2 Crioestaminal Main Business
7.8.3 Crioestaminal Stem Cell Banking Products, Services and Solutions
7.8.4 Crioestaminal Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.8.5 Crioestaminal Recent Developments
7.9 RMS Regrow
7.9.1 RMS Regrow Profile
7.9.2 RMS Regrow Main Business
7.9.3 RMS Regrow Stem Cell Banking Products, Services and Solutions
7.9.4 RMS Regrow Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.9.5 RMS Regrow Recent Developments
7.10 Cordlife
7.10.1 Cordlife Profile
7.10.2 Cordlife Main Business
7.10.3 Cordlife Stem Cell Banking Products, Services and Solutions
7.10.4 Cordlife Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.10.5 Cordlife Recent Developments
7.11 PBKM FamiCord
7.11.1 PBKM FamiCord Profile
7.11.2 PBKM FamiCord Main Business
7.11.3 PBKM FamiCord Stem Cell Banking Products, Services and Solutions
7.11.4 PBKM FamiCord Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.11.5 PBKM FamiCord Recent Developments
7.12 cells4life
7.12.1 cells4life Profile
7.12.2 cells4life Main Business
7.12.3 cells4life Stem Cell Banking Products, Services and Solutions
7.12.4 cells4life Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.12.5 cells4life Recent Developments
7.13 Beikebiotech
7.13.1 Beikebiotech Profile
7.13.2 Beikebiotech Main Business
7.13.3 Beikebiotech Stem Cell Banking Products, Services and Solutions
7.13.4 Beikebiotech Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.13.5 Beikebiotech Recent Developments
7.14 StemCyte
7.14.1 StemCyte Profile
7.14.2 StemCyte Main Business
7.14.3 StemCyte Stem Cell Banking Products, Services and Solutions
7.14.4 StemCyte Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.14.5 StemCyte Recent Developments
7.15 Cryo-cell
7.15.1 Cryo-cell Profile
7.15.2 Cryo-cell Main Business
7.15.3 Cryo-cell Stem Cell Banking Products, Services and Solutions
7.15.4 Cryo-cell Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.15.5 Cryo-cell Recent Developments
7.16 Cellsafe Biotech
7.16.1 Cellsafe Biotech Profile
7.16.2 Cellsafe Biotech Main Business
7.16.3 Cellsafe Biotech Stem Cell Banking Products, Services and Solutions
7.16.4 Cellsafe Biotech Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.16.5 Cellsafe Biotech Recent Developments
7.17 PacifiCord
7.17.1 PacifiCord Profile
7.17.2 PacifiCord Main Business
7.17.3 PacifiCord Stem Cell Banking Products, Services and Solutions
7.17.4 PacifiCord Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.17.5 PacifiCord Recent Developments
7.18 Americord
7.18.1 Americord Profile
7.18.2 Americord Main Business
7.18.3 Americord Stem Cell Banking Products, Services and Solutions
7.18.4 Americord Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.18.5 Americord Recent Developments
7.19 Krio
7.19.1 Krio Profile
7.19.2 Krio Main Business
7.19.3 Krio Stem Cell Banking Products, Services and Solutions
7.19.4 Krio Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.19.5 Krio Recent Developments
7.20 Familycord
7.20.1 Familycord Profile
7.20.2 Familycord Main Business
7.20.3 Familycord Stem Cell Banking Products, Services and Solutions
7.20.4 Familycord Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.20.5 Familycord Recent Developments
7.21 Cryo Stemcell
7.21.1 Cryo Stemcell Profile
7.21.2 Cryo Stemcell Main Business
7.21.3 Cryo Stemcell Stem Cell Banking Products, Services and Solutions
7.21.4 Cryo Stemcell Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.21.5 Cryo Stemcell Recent Developments
7.22 Stemade Biotech
7.22.1 Stemade Biotech Profile
7.22.2 Stemade Biotech Main Business
7.22.3 Stemade Biotech Stem Cell Banking Products, Services and Solutions
7.22.4 Stemade Biotech Stem Cell Banking Revenue (US$ Million) & (2020-2025)
7.22.5 Stemade Biotech Recent Developments
8 Industry Chain Analysis
8.1 Stem Cell Banking Industrial Chain
8.2 Stem Cell Banking Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Stem Cell Banking Sales Model
8.5.2 Sales Channel
8.5.3 Stem Cell Banking Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer